DM21 is a drug-linker conjugate designed for use in antibody-drug conjugates (ADCs). It features a maytansinoid microtubule-disrupting payload linked through a stable tripeptide linker, enhancing its therapeutic efficacy. DM21 is conjugated with a humanized antibody targeting ADAM9, resulting in the formulation of IMGC936, which holds promise in cancer research and targeted therapies.
DM21 is a drug-linker conjugate designed for use in antibody-drug conjugates (ADCs). It features a maytansinoid microtubule-disrupting payload linked through a stable tripeptide linker, enhancing its therapeutic efficacy. DM21 is conjugated with a humanized antibody targeting ADAM9, resulting in the formulation of IMGC936, which holds promise in cancer research and targeted therapies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: